Dr. Riddhishkumar Shah
Overview
I've been working in healthcare for over two decades, and what I like most about it is getting to know my patients well. When someone is told they have cancer, it's incredibly scary. But the good news is that there are better treatments now that can provide hope. My team and I make an effort to understand our patients, learn what's important to them, and support them through the challenging times. We use my knowledge and experience to lead a team of different experts who collaborate to try to cure cancer when possible and create treatment plans that align with the patient's preferences. I'm also well-versed in new and upcoming treatments due to my work in cancer research. I can explain them in simple terms so that everyone can understand, which helps patients feel more confident and engaged. I specialize in treating skin cancers like melanoma, Merkel cell carcinoma, and cancers that arise in the gastrointestinal tract, including colon and rectum. Outside of work, I'm a family man with a loving wife and two kids. We thoroughly enjoy living in North Carolina, with its beautiful scenery and outdoor activities such as hiking and sports. I've had the privilege of helping many patients, and I look forward to being there for you too.
Dr. Shah is rated as an Experienced provider by MediFind in the treatment of Pancreatic Cancer. His top areas of expertise are Colorectal Cancer, Multiple Myeloma, Pulmonary Embolism, Pancreatic Cancer, and Endoscopy.
His clinical research consists of co-authoring 4 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Pancreatic Cancer.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- HMO
- POS
- INSURANCE PLAN
- MEDICARE MAPD
- OTHER COMMERCIAL
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
216 Ashville Ave, Cary, NC 27518
Additional Areas of Focus
Dr. Shah has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Duke Cancer Center
Diane Reidy-Lagunes is a Hematologist Oncology specialist and a Hematologist in Durham, North Carolina. Dr. Reidy-Lagunes is rated as an Elite provider by MediFind in the treatment of Pancreatic Cancer. Her top areas of expertise are Neuroendocrine Tumor, Pancreatic Islet Cell Tumor, Pancreatic Cancer, Pancreaticoduodenectomy, and Liver Embolization.
Duke Cancer Center
My passion is the treatment of patients with gastrointestinal (GI) malignancies. I strive to take the very best care of my patients that I possibly can. Working with world-class colleagues and a multidisciplinary team, which includes radiation and surgical oncologists, makes this possible. I first became interested in oncology as a first-year medical student when I got to see tumors in my pathology class. I came to appreciate the beauty of the gastrointestinal tract while observing GI surgeries as a second-year medical student. My fascination with how cancers develop and how we may develop new therapies to treat cancer led me to pursue a PhD in molecular cancer biology. This training honed the critical thinking skills that I still use to this day, as I decide how to best treat my patients. The close relationships that oncologists have with patients and their families clinched my decision to pursue a career as a medical oncologist. During my fellowship training, I sought out subspecialty training in GI oncology. When I am not working, I enjoy spending time with my husband and four young children and running. Dr. Mettu is rated as a Distinguished provider by MediFind in the treatment of Pancreatic Cancer. Her top areas of expertise are Pancreatic Cancer, Colorectal Cancer, Familial Pancreatic Cancer, and Familial Colorectal Cancer.
Duke Raleigh Hematology Oncology Clinic
Neeraj Ramvishal-Agrawal is an Oncologist and a Hematologist in Raleigh, North Carolina. Dr. Ramvishal-Agrawal is rated as a Distinguished provider by MediFind in the treatment of Pancreatic Cancer. His top areas of expertise are Familial Colorectal Cancer, Colorectal Cancer, Lynch Syndrome, Pancreatoblastoma, and Colonoscopy. Dr. Ramvishal-Agrawal is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Colorectal CancerDr. Shah isDistinguished. Learn about Colorectal Cancer.
- Advanced
- Multiple MyelomaDr. Shah isAdvanced. Learn about Multiple Myeloma.
- Experienced
- Arterial EmbolismDr. Shah isExperienced. Learn about Arterial Embolism.
- EndoscopyDr. Shah isExperienced. Learn about Endoscopy.
- Gastroesophageal Junction CancerDr. Shah isExperienced. Learn about Gastroesophageal Junction Cancer.
- Marginal Zone Lymphoma (MZL)Dr. Shah isExperienced. Learn about Marginal Zone Lymphoma (MZL).
- MelanomaDr. Shah isExperienced. Learn about Melanoma.
- Pancreatic CancerDr. Shah isExperienced. Learn about Pancreatic Cancer.